Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
Condition(s):Retinal Vein Occlusion; Macular EdemaLast Updated:April 16, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Retinal Vein Occlusion; Macular EdemaLast Updated:April 16, 2013Completed
Condition(s):Retinal Vein OcclusionLast Updated:May 17, 2016Completed
Condition(s):Retinitis PigmentosaLast Updated:May 29, 2015Unknown status
Condition(s):Diabetic Macular EdemaLast Updated:February 19, 2019Completed
Condition(s):Dry Macular Degeneration; Geographic AtrophyLast Updated:May 29, 2020Active, not recruiting
Condition(s):Retinitis Pigmentosa; ChoroideremiaLast Updated:September 11, 2020Enrolling by invitation
Condition(s):Macular Edema; Epiretinal Membrane; VitrectomyLast Updated:October 3, 2018Terminated
Condition(s):Diabetic Macular Oedema; Retinal Vein Occlusion With Macular OedemaLast Updated:April 19, 2021Recruiting
Condition(s):Macular DegenerationLast Updated:November 16, 2016Completed
Condition(s):Age Related Macular DegenerationLast Updated:November 1, 2019Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.